Baxter International Inc. (BAX) reported third-quarter 2024 adjusted earnings per share (EPS) of 80 cents, which beat the Zacks Consensus Estimate of 78 cents by 2.6%. The bottom line declined 2.4% from the year-ago quarter’s level.On a GAAP basis, the company reported EPS of 27 cents compared with $4.93 in the prior-year quarter.The company reported adjusted EPS from continuing operations, which include Medical Products & Therapies, Healthcare Systems & Technologies and Pharmaceuticals segments, of 49 cent ...